COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 2,160 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
ADICET BIO INC | COM | 007002108 | 1,861 | 142,289 | SH | | SOLE | | 142,289 | 0 | 0 |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,121 | 267,753 | SH | | SOLE | | 267,753 | 0 | 0 |
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 6,513 | 548,225 | SH | | SOLE | | 548,225 | 0 | 0 |
ALPHA HEALTHCARE ACQUISTN CO | UNIT 09/21/2027 | 020751202 | 3,436 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
AMPLITUDE HLTHCRE AQUSTIN CO | *W EXP 12/01/202 | 03212A113 | 133 | 162,500 | SH | | SOLE | | 162,500 | 0 | 0 |
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 3,297 | 113,962 | SH | | SOLE | | 113,962 | 0 | 0 |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 5,310 | 408,908 | SH | | SOLE | | 408,908 | 0 | 0 |
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,983 | 440,589 | SH | | SOLE | | 440,589 | 0 | 0 |
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 3,895 | 178,600 | SH | | SOLE | | 178,600 | 0 | 0 |
BCTG ACQUISITION CORP | COM | 05492W103 | 1,334 | 120,000 | SH | | SOLE | | 120,000 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 6,042 | 1,573,389 | SH | | SOLE | | 1,573,389 | 0 | 0 |
BRAINSWAY LTD | SPONSORED ADS | 10501L106 | 1,621 | 179,506 | SH | | SOLE | | 179,506 | 0 | 0 |
BRIACELL THERAPEUTICS CORP | *W EXP 02/24/202 | 10778Y112 | 535 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
CTI BIOPHARMA CORP | COM | 12648L601 | 1,714 | 588,992 | SH | | SOLE | | 588,992 | 0 | 0 |
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 2,066 | 853,902 | SH | | SOLE | | 853,902 | 0 | 0 |
CAREDX INC | COM | 14167L103 | 5,535 | 81,284 | SH | | SOLE | | 81,284 | 0 | 0 |
CASTLE BIOSCIENCES INC | COM | 14843C105 | 1,873 | 27,365 | SH | | SOLE | | 27,365 | 0 | 0 |
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 453 | 89,930 | SH | | SOLE | | 89,930 | 0 | 0 |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 927 | 45,013 | SH | | SOLE | | 45,013 | 0 | 0 |
CELSION CORP | COM PAR NEW | 15117N503 | 4,825 | 3,496,154 | SH | | SOLE | | 3,496,154 | 0 | 0 |
CHARDAN HEALTHCR ACQSTN 2 CO | COM | 15957T107 | 7,571 | 753,374 | SH | | SOLE | | 753,374 | 0 | 0 |
CHARDAN HEALTHCR ACQSTN 2 CO | *W EXP 03/05/202 | 15957T115 | 688 | 731,561 | SH | | SOLE | | 731,561 | 0 | 0 |
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 3,198 | 205,799 | SH | | SOLE | | 205,799 | 0 | 0 |
CM LIFE SCIENCES INC | COM CL A | 18978W109 | 1,489 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
CM LIFE SCIENCES INC | *W EXP 09/04/202 | 18978W117 | 345 | 66,666 | SH | | SOLE | | 66,666 | 0 | 0 |
COHERUS BIOSCIENCES INC | COM | 19249H103 | 1,996 | 136,623 | SH | | SOLE | | 136,623 | 0 | 0 |
CONFORMIS INC | COM | 20717E101 | 2,583 | 2,608,875 | SH | | SOLE | | 2,608,875 | 0 | 0 |
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 3,713 | 158,733 | SH | | SOLE | | 158,733 | 0 | 0 |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 5,530 | 361,930 | SH | | SOLE | | 361,930 | 0 | 0 |
CURIS INC | COM NEW | 231269200 | 8,739 | 772,009 | SH | | SOLE | | 772,009 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 2,402 | 103,262 | SH | | SOLE | | 103,262 | 0 | 0 |
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 3,734 | 483,041 | SH | | SOLE | | 483,041 | 0 | 0 |
DYNE THERAPEUTICS INC | COM | 26818M108 | 2,588 | 166,636 | SH | | SOLE | | 166,636 | 0 | 0 |
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,748 | 197,500 | SH | | SOLE | | 197,500 | 0 | 0 |
ESSA PHARMA INC | COM NEW | 29668H708 | 6,683 | 230,063 | SH | | SOLE | | 230,063 | 0 | 0 |
EVAXION BIOTECH A S | ADS | 29970R105 | 146 | 24,725 | SH | | SOLE | | 24,725 | 0 | 0 |
EXAGEN INC | COM | 30068X103 | 1,513 | 86,475 | SH | | SOLE | | 86,475 | 0 | 0 |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,939 | 289,316 | SH | | SOLE | | 289,316 | 0 | 0 |
FAT BRANDS INC | *W EXP 06/30/202 | 30258N121 | 1,056 | 300,000 | SH | | SOLE | | 300,000 | 0 | 0 |
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,992 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
FIRSTMARK HORIZON ACQUISITIO | CL A COM | 33765Y101 | 1,000 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
FORTE BIOSCIENCES INC | COM | 34962G109 | 4,611 | 134,542 | SH | | SOLE | | 134,542 | 0 | 0 |
GEMINI THERAPEUTICS INC | COM | 36870G105 | 2,764 | 203,995 | SH | | SOLE | | 203,995 | 0 | 0 |
GENPREX INC | COM | 372446104 | 263 | 60,909 | SH | | SOLE | | 60,909 | 0 | 0 |
GIGCAPITAL4 INC | UNIT 99/99/9999 | 37518G200 | 1,234 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
GLAUKOS CORP | COM | 377322102 | 3,424 | 40,800 | SH | | SOLE | | 40,800 | 0 | 0 |
GLOBUS MED INC | CL A | 379577208 | 3,013 | 48,862 | SH | | SOLE | | 48,862 | 0 | 0 |
HAEMONETICS CORP MASS | COM | 405024100 | 1,892 | 17,044 | SH | | SOLE | | 17,044 | 0 | 0 |
HARPOON THERAPEUTICS INC | COM | 41358P106 | 4,176 | 199,607 | SH | | SOLE | | 199,607 | 0 | 0 |
ILLUMINA INC | COM | 452327109 | 3,072 | 8,000 | SH | | SOLE | | 8,000 | 0 | 0 |
IMMUNOVANT INC | COM | 45258J102 | 3,683 | 229,622 | SH | | SOLE | | 229,622 | 0 | 0 |
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 3,141 | 972,327 | SH | | SOLE | | 972,327 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 3,755 | 110,254 | SH | | SOLE | | 110,254 | 0 | 0 |
INSULET CORP | COM | 45784P101 | 5,479 | 21,000 | SH | | SOLE | | 21,000 | 0 | 0 |
INTERSECT ENT INC | COM | 46071F103 | 2,962 | 141,856 | SH | | SOLE | | 141,856 | 0 | 0 |
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,997 | 88,326 | SH | | SOLE | | 88,326 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 5,578 | 902,633 | SH | | SOLE | | 902,633 | 0 | 0 |
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,968 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,292 | 128,130 | SH | | SOLE | | 128,130 | 0 | 0 |
LANDCADIA HOLDINGS III INC | COM CL A | 51476H100 | 1,925 | 192,314 | SH | | SOLE | | 192,314 | 0 | 0 |
LANTHEUS HLDGS INC | COM | 516544103 | 5,878 | 275,066 | SH | | SOLE | | 275,066 | 0 | 0 |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,363 | 93,261 | SH | | SOLE | | 93,261 | 0 | 0 |
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 2,535 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
MEI PHARMA INC | COM NEW | 55279B202 | 2,189 | 638,083 | SH | | SOLE | | 638,083 | 0 | 0 |
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 1,946 | 164,381 | SH | | SOLE | | 164,381 | 0 | 0 |
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 4,213 | 1,250,000 | SH | | SOLE | | 1,250,000 | 0 | 0 |
MORPHIC HLDG INC | COM | 61775R105 | 2,945 | 46,541 | SH | | SOLE | | 46,541 | 0 | 0 |
MYRIAD GENETICS INC | COM | 62855J104 | 5,231 | 171,785 | SH | | SOLE | | 171,785 | 0 | 0 |
NEURONETICS INC | COM | 64131A105 | 1,701 | 137,500 | SH | | SOLE | | 137,500 | 0 | 0 |
NEVRO CORP | COM | 64157F103 | 5,287 | 37,900 | SH | | SOLE | | 37,900 | 0 | 0 |
NEWAGE INC | COM | 650194103 | 3,427 | 1,198,150 | SH | | SOLE | | 1,198,150 | 0 | 0 |
NUVASIVE INC | COM | 670704105 | 2,828 | 43,133 | SH | | SOLE | | 43,133 | 0 | 0 |
OCULAR THERAPEUTIX INC | COM | 67576A100 | 5,313 | 326,174 | SH | | SOLE | | 326,174 | 0 | 0 |
OCUPHIRE PHARMA INC # | COM | 67577R102 | 2,306 | 397,036 | SH | | SOLE | | 397,036 | 0 | 0 |
ONCTERNAL THERAPEUTICS INC | COM | 68236P107 | 1,467 | 176,287 | SH | | SOLE | | 176,287 | 0 | 0 |
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 2,682 | 775,000 | SH | | SOLE | | 775,000 | 0 | 0 |
PROFOUND MED CORP | COM NEW | 74319B502 | 2,546 | 126,427 | SH | | SOLE | | 126,427 | 0 | 0 |
PROGENITY INC | COM | 74319F107 | 8,322 | 1,748,252 | SH | | SOLE | | 1,748,252 | 0 | 0 |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,173 | 238,354 | SH | | SOLE | | 238,354 | 0 | 0 |
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 4,743 | 223,000 | SH | | SOLE | | 223,000 | 0 | 0 |
ROTH CH ACQUISITION II CO | UNIT 12/11/2025 | 778673202 | 1,054 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
SALARIUS PHARMACEUTICALS INC | COM NEW | 79400X107 | 1,850 | 1,250,110 | SH | | SOLE | | 1,250,110 | 0 | 0 |
SERES THERAPEUTICS INC | COM | 81750R102 | 2,154 | 104,626 | SH | | SOLE | | 104,626 | 0 | 0 |
SIENTRA INC | COM | 82621J105 | 5,388 | 739,045 | SH | | SOLE | | 739,045 | 0 | 0 |
SUPERNOVA PARTNERS ACQUISITI | COM CL A | 86846V108 | 1,011 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
SUTRO BIOPHARMA INC | COM | 869367102 | 5,160 | 226,719 | SH | | SOLE | | 226,719 | 0 | 0 |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 5,667 | 253,448 | SH | | SOLE | | 253,448 | 0 | 0 |
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 948 | 126,702 | SH | | SOLE | | 126,702 | 0 | 0 |
TFF PHARMACEUTICALS INC | COM | 87241J104 | 3,660 | 269,691 | SH | | SOLE | | 269,691 | 0 | 0 |
TAILWIND ACQUISITION CORP | COM CL A | 87403Q102 | 1,274 | 128,414 | SH | | SOLE | | 128,414 | 0 | 0 |
TCR2 THERAPEUTICS INC | COM | 87808K106 | 4,618 | 209,130 | SH | | SOLE | | 209,130 | 0 | 0 |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 5,256 | 210,484 | SH | | SOLE | | 210,484 | 0 | 0 |
VALLON PHARMACEUTICALS INC | COM | 92023M101 | 1,392 | 300,000 | SH | | SOLE | | 300,000 | 0 | 0 |
VAREX IMAGING CORP | COM | 92214X106 | 2,166 | 105,727 | SH | | SOLE | | 105,727 | 0 | 0 |
VERASTEM INC | COM | 92337C104 | 6,356 | 2,573,222 | SH | | SOLE | | 2,573,222 | 0 | 0 |
VERB TECHNOLOGY CO INC | COM | 92337U104 | 394 | 281,173 | SH | | SOLE | | 281,173 | 0 | 0 |
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 8,529 | 562,954 | SH | | SOLE | | 562,954 | 0 | 0 |
VIEWRAY INC | COM | 92672L107 | 1,258 | 289,114 | SH | | SOLE | | 289,114 | 0 | 0 |
VINCERX PHARMA INC | *W EXP 12/24/202 | 92731L114 | 870 | 215,250 | SH | | SOLE | | 215,250 | 0 | 0 |
YUMANITY THERAPEUTICS INC | COM | 98872L102 | 1,967 | 108,695 | SH | | SOLE | | 108,695 | 0 | 0 |
ACE CONVERGENCE ACQU CORP | CL A | G0083D120 | 1,884 | 189,000 | SH | | SOLE | | 189,000 | 0 | 0 |
AJAX I | COM | G0190X100 | 1,026 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,057 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
CITIC CAPITAL ACQUISITION CO | COM CL A | G21513109 | 1,000 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 2,440 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 4,005 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,047 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
ARYA SCIENCES ACQUISITION CO | COM CL A | G3166W106 | 3,946 | 286,383 | SH | | SOLE | | 286,383 | 0 | 0 |
GALILEO ACQUISITION CORP | *W EXP 10/31/202 | G3770A110 | 110 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 112 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 2,000 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,550 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
MOTIVE CAPITAL CORP | SHS CL A | G6293A103 | 1,001 | 102,099 | SH | | SOLE | | 102,099 | 0 | 0 |
NOCTURNE ACQUISITION CORP | UNIT 02/25/2026 | G6580S122 | 5,000 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
OMEGA ALPHA SPAC | CL A | G6749V107 | 990 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
QELL ACQUISITION CORP | CL A | G7307X105 | 1,018 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 2,437 | 225,000 | SH | | SOLE | | 225,000 | 0 | 0 |
TURMERIC ACQUISITION CORP | UNIT 10/08/2025 | G9127T116 | 2,540 | 254,000 | SH | | SOLE | | 254,000 | 0 | 0 |
IMMATICS N.V | SHS | N44445109 | 3,862 | 344,558 | SH | | SOLE | | 344,558 | 0 | 0 |
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 288 | 97,467 | SH | | SOLE | | 97,467 | 0 | 0 |
INFLARX NV | COM | N44821101 | 3,021 | 774,600 | SH | | SOLE | | 774,600 | 0 | 0 |
PYXIS TANKERS INC | COM | Y71726106 | 2,097 | 2,035,793 | SH | | SOLE | | 2,035,793 | 0 | 0 |
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 2,238 | 398,997 | SH | | SOLE | | 398,997 | 0 | 0 |